Metabolic syndrome (MetS) is a constellation of abnormalities that increase the risk of coronary heart disease and diabetes mellitus (DM).
5
The diagnostic criteria is dictated by the International Diabetes Federation, the National Heart Lung Blood Institute, and the American Heart Association, among others. The prevalence is highly variable due to the different diagnostic criteria, but generally increases with age and is more frequent in men older than 20 yr with an estimated 17–40%, 30% in the age range from 40–50 yr, and 40–45% in those older than 50 yr